No definition available.
Other demyelinating diseases of the central nervous system
DOID EFO Endpoint Browser PheWeb
G6_OTHDEMYEL
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1458 |
4. Check minimum number of eventsNone |
1458 |
5. Include endpointsNone |
1458 |
6. Filter based on genotype QC (FinnGen only) |
1458 |
Control definitions (FinnGen only)
- Control exclude
- G6_DEMYEL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G35-G37
- Name in latin
- Alii morbi demyelinantes systematis nervosi centralis
Similar endpoints
↥List of similar endpoints to
Other demyelinating diseases of the central nervous system
based on the number of shared cases.
Similar with more cases:
- Demyelinating diseases of the central nervous system
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8543 | 5445 | 3043 |
| Only index persons | 7717 | 5057 | 2660 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.16 | 0.09 |
| Only index persons | 0.16 | 0.19 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 39.82 | 38.63 | 41.86 |
| Only index persons | 39.14 | 38.08 | 41.15 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1458 | 1059 | 399 |
| Unadjusted period prevalence (%) | 0.31 | 0.36 | 0.18 |
| Median age at first event (years) | 39.28 | 37.77 | 43.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1322
- Matched controls
- 13217
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
25.5
323.0
662
500
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
323.0
1024
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
323.0
544
*
G35
ICD-10 Finland
Multiple sclerosis
10640.8
323.0
869
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
323.0
659
*
TAB00
NOMESCO Finland
Lumbar puncture
27.7
323.0
500
284
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
560
*
L03AB07
ATC
interferon beta-1a; parenteral
+∞
302.0
278
*
N86
ICPC
Multiple sclerosis
1074.9
275.2
260
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
244.6
227
*
H46
ICD-10 Finland
Optic neuritis
118.9
228.3
243
25
L04AX07
ATC
dimethyl fumarate; oral
+∞
207.9
194
*
L04AA31
ATC
teriflunomide; oral
+∞
180.4
169
*
164
Kela drug reimbursment
Fingolimod
+∞
170.6
160
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
149.9
141
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
41.1
134.2
169
47
R20.2
ICD-10 Finland
Paraesthesia of skin
8.1
125.3
308
475
L03AB08
ATC
interferon beta-1b; parenteral
+∞
121.8
115
*
L04AA27
ATC
fingolimod; oral
+∞
118.6
112
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.5
117.2
306
513
N04BB01
ATC
amantadine; oral
38.9
117.0
149
43
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
116.4
110
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
107.8
102
*
M03BX01
ATC
baclofen; systemic
25.1
101.0
144
64
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
17.5
99.7
161
104
2AB04
NOMESCO Finland
NA
940.5
90.9
88
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
20.3
87.9
134
73
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.8
87.8
217
325
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.8
85.3
268
556
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.2
77.0
151
150
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
75.8
72
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
73.5
351
1107
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
23.9
69.5
100
45
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
13.2
67.2
121
100
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
67.1
163
234
XCK00
NOMESCO Finland
Perimetry
6.8
63.6
171
284
XKD06
NOMESCO Finland
Physiologic investigation of micturition
11.9
59.9
113
103
G37.2
ICD-10 Finland
Central pontine myelinolysis
+∞
58.8
56
*
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
58.8
56
*
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
+∞
54.6
52
*
G04BD12
ATC
mirabegron; oral
5.1
53.3
183
407
H53.2
ICD-10 Finland
Diplopia
9.5
51.4
109
124
ZX120
NOMESCO Finland
Intravenous
4.2
49.8
208
563
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
35.3
49.6
64
19
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
49.3
47
*
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
49.3
47
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
25.0
48.9
69
29
N03AX12
ATC
gabapentin; oral
3.2
47.6
294
1092
XKD00
NOMESCO Finland
Uroflowmetry
4.2
46.4
191
508
N06BA07
ATC
modafinil; oral
50.1
44.2
53
11
N03AE01
ATC
clonazepam; systemic
5.0
43.6
148
323
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
16.6
42.1
68
43
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
41.9
40
*
UKC02
NOMESCO Finland
Cystoscopy
3.5
41.3
214
691
G04BD09
ATC
trospium; oral
10.5
41.1
82
83
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.3
40.7
163
420
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
8.9
39.8
87
104
4AA23
NOMESCO Finland
NA
377.6
37.2
37
*
N03AX16
ATC
pregabalin; oral
2.4
35.9
365
1794
XKC03
NOMESCO Finland
Water cystometry
7.1
35.6
90
135
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
35.3
136
337
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
33.4
505
2970
L04AA40
ATC
cladribine; oral
+∞
31.4
30
*
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
31.4
30
*
R1250
NOMESCO Finland
Evaluation of functional capability
8.0
30.8
71
93
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
29.8
375
2013
G04BD08
ATC
solifenacin; oral
4.8
28.9
99
217
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
14.2
28.2
48
35
TKC22
NOMESCO Finland
Catheterisation instruction
10.6
28.1
55
54
L28
ICPC
Limited function/disability (L)
2.9
27.2
182
694
H53.1
ICD-10 Finland
Subjective visual disturbances
3.6
26.8
127
377
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.1
26.3
48
41
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
26.1
25
*
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.9
25.5
65
99
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.5
25.4
127
393
R33
ICD-10 Finland
Retention of urine
4.7
24.9
88
199
N29
ICPC
Neurological sympt/complt other
9.0
24.9
53
61
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
24.0
23
*
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
24.0
23
*
SPAT1229
SPAT
Assessment of need for aid
3.7
23.6
107
306
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.5
23.6
62
99
AA1AD
NOMESCO Finland
CT of head and brain
2.2
23.5
273
1392
L01BB04
ATC
cladribine; systemic
+∞
23.0
22
*
A02BC02
ATC
pantoprazole; systemic
1.8
22.3
811
6227
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
24.4
22.2
31
13
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
22.1
211
976
R35
ICD-10 Finland
Polyuria
4.0
22.0
92
245
G04BD04
ATC
oxybutynin; oral, transdermal
4.3
22.0
84
206
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.3
21.9
68
134
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.4
21.4
79
187
H02AB04
ATC
methylprednisolone; systemic
2.3
21.2
222
1071
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.4
21.1
56
91
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.8
20.7
145
565
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
30.6
20.6
27
9
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.8
20.6
70
153
N28
ICPC
Limited function/disability (N)
11.5
20.5
38
34
CS494
NOMESCO Finland
Other visual field testing
6.8
20.1
51
78
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
9.8
19.9
40
42
34099
ICD-8 Finland
Multiple sclerosis
+∞
19.8
19
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
25.0
19.6
27
11
R42
ICD-10 Finland
Dizziness and giddiness
2.1
19.5
261
1402
N05CF01
ATC
zopiclone; oral
1.8
19.2
382
2385
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
20.4
19.1
28
14
N99
ICPC
Neurological disease other
12.0
18.8
34
29
4AA36
NOMESCO Finland
NA
+∞
18.8
18
*
34108
ICD-8 Finland
Other demyelinating diseases of central nervous system, Alii definiti
+∞
18.8
18
*
N06AX21
ATC
duloxetine; oral
2.3
18.5
184
864
TKC20
NOMESCO Finland
Catheterisation of bladder
3.5
18.4
87
258
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
30.5
18.4
24
8
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
18.2
89
271
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
18.0
156
684
G37.1
ICD-10 Finland
Central demyelination of corpus callosum
+∞
17.7
17
*
N03AF01
ATC
carbamazepine; oral, rectal
3.6
17.6
82
240
N06AX16
ATC
venlafaxine; oral
2.0
17.4
240
1301
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
12.2
17.4
31
26
G04BD07
ATC
tolterodine; oral
4.2
17.3
67
167
C10AC01
ATC
colestyramine; oral
4.6
17.3
61
139
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.3
17.3
32
29
J01EA01
ATC
trimethoprim; systemic
1.8
17.2
343
2132
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.2
16.8
90
294
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
91.2
16.6
18
*
L04AX01
ATC
azathioprine; systemic
3.2
16.3
87
283
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
12.4
15.9
28
23
R4110
NOMESCO Finland
Physiotherapy
1.8
15.7
323
2015
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
15.7
107
409
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
15.4
87
293
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.7
15.2
43
77
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
14.6
14
*
N06AA09
ATC
amitriptyline; systemic
2.4
14.4
128
567
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
11.0
14.0
26
24
R4150
NOMESCO Finland
Neuropsychological rehabilitation
8.3
13.8
30
37
SPAT1216
SPAT
Assessment of functional ability
2.2
13.8
146
706
R4120
NOMESCO Finland
Occupational therapy
2.7
13.5
95
370
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.5
13.5
31
42
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.7
13.1
92
359
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.6
12.9
37
68
A28
ICPC
Limited function/disability NOS
2.3
12.7
115
516
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.6
265
1652
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
11.1
12.5
23
21
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
12.3
77
281
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.6
12.3
42
94
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
12.2
94
387
R39.1
ICD-10 Finland
Other difficulties with micturition
4.5
12.2
42
95
G04BD11
ATC
fesoterodine; oral
4.8
12.2
40
86
G61.0
ICD-10 Finland
Guillain-Barré syndrome
16.0
12.2
19
12
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
6.6
12.1
30
46
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.9
12.0
49
130
R51.80
ICD-10 Finland
Headache
1.8
12.0
228
1376
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
12.0
117
541
N30.0
ICD-10 Finland
Acute cystitis
1.9
12.0
181
1007
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
11.8
161
864
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
19.1
11.6
17
9
R20.1
ICD-10 Finland
Hypoaesthesia of skin
9.3
11.5
23
25
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.8
11.4
48
131
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.3
11.2
33
63
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
17.2
11.2
17
10
R27.0
ICD-10 Finland
Ataxia, unspecified
20.2
11.1
16
8
H30.2
ICD-10 Finland
Posterior cyclitis
15.6
10.8
17
11
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.8
10.7
26
39
H57.1
ICD-10 Finland
Ocular pain
3.2
10.7
55
177
H47.2
ICD-10 Finland
Optic atrophy
14.3
10.5
17
12
U13
ICPC
Bladder symptom/complaint other
3.7
10.5
45
126
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
110.9
10.4
11
*
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
18.9
10.3
15
8
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
13.2
10.2
17
13
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
10.1
144
783
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
10.0
101
477
M03BX02
ATC
tizanidine; oral
1.5
9.9
826
7040
N03AF02
ATC
oxcarbazepine; oral
2.9
9.8
57
200
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
9.8
153
864
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.8
9.7
31
66
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
9.6
117
601
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
100.7
9.4
10
*
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
100.7
9.4
10
*
H02AB06
ATC
prednisolone; systemic
1.5
9.4
536
4220
3418X
ICD-9 Finland
Other demyelinating diseases of central nervous system
+∞
9.4
9
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.1
9.3
50
167
A06AD11
ATC
lactulose; oral
2.0
9.3
124
658
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
9.2
72
298
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
7.1
9.0
21
30
N18
ICPC
Paralysis/weakness
5.5
8.9
25
46
R52.2
ICD-10 Finland
Other chronic pain
3.0
8.7
50
173
6BA02
NOMESCO Finland
NA
14.1
8.7
14
10
WW400
NOMESCO Finland
Plasmaferesis
50.3
8.7
10
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.7
8.7
19
25
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.6
406
3062
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.6
494
3879
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
8.3
8.6
18
22
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
8.5
59
232
H53.4
ICD-10 Finland
Visual field defects
3.9
8.4
33
87
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
+∞
8.3
8
*
G37.5
ICD-10 Finland
Concentric sclerosis [Baló]
+∞
8.3
8
*
RS221
NOMESCO Finland
NA
4.2
8.3
30
73
G04CA02
ATC
tamsulosin; oral
1.9
8.3
128
718
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
9.5
8.3
16
17
H25.8
ICD-10 Finland
Other senile cataract
2.6
8.2
57
225
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
7.6
8.2
18
24
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
8.1
114
619
H02AB07
ATC
prednisone; oral
1.7
8.1
162
989
R47.1
ICD-10 Finland
Dysarthria and anarthria
9.0
8.0
16
18
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
22.2
8.0
11
5
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
13.1
7.9
13
10
R20.0
ICD-10 Finland
Anaesthesia of skin
5.7
7.8
21
37
WX110
NOMESCO Finland
Local anesthesy
1.4
7.8
891
7858
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.5
7.8
34
98
XA402
NOMESCO Finland
ENMG
3.3
7.8
37
114
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.9
7.7
30
79
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.7
7.5
49
186
N06
ICPC
Sensation disturbance other
5.5
7.5
21
39
N06AB04
ATC
citalopram; systemic
1.5
7.5
261
1838
SPAT1167
SPAT
Insertion of urinary catheter
4.4
7.3
25
58
N02BE01
ATC
paracetamol; systemic, rectal
1.5
7.3
1052
9620
RS121
NOMESCO Finland
NA
6.9
7.3
17
25
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
7.3
7
*
SPAT1263
SPAT
Sampling
1.4
7.2
491
3940
Z43.5
ICD-10 Finland
Attention to cystostomy
15.8
7.2
11
7
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.5
7.2
32
94
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
7.2
114
646
SPAT1262
SPAT
Handing over of treatment supplies
1.7
7.2
165
1046
R60.0
ICD-10 Finland
Localized oedema
1.9
7.2
102
555
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
20.1
7.1
10
5
SPAT1301
SPAT
No procedures
1.4
7.1
332
2485
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
7.1
113
643
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.7
7.1
19
34
S97
ICPC
Chronic ulcer skin
2.8
7.1
45
167
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
7.1
99
536
U04
ICPC
Incontinence urine
2.8
6.9
42
154
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
4.3
6.9
24
57
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
6.8
97
530
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.2
6.8
67
315
R13
ICD-10 Finland
Dysphagia
2.2
6.8
67
316
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
6.7
160
1028
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.6
490
3974
A06AC51
ATC
ispaghula, combinations; systemic
2.4
6.5
55
239
359
Kela drug reimbursment
Mirabegroni
10.1
6.5
12
12
RS222
NOMESCO Finland
NA
4.2
6.5
23
56
J05AB11
ATC
valaciclovir; oral
1.6
6.5
157
1011
M79.6
ICD-10 Finland
Pain in limb
1.4
6.5
397
3120
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.4
419
3328
R15
ICD-10 Finland
Faecal incontinence
3.2
6.4
31
99
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
8.2
6.3
13
16
SPAT1325
SPAT
Vaccination
1.4
6.3
304
2284
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.6
6.3
26
73
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
9.3
6.3
12
13
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
18.1
6.3
9
5
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
6.2
51
221
5AB01
NOMESCO Finland
NA
26.8
6.2
8
*
Z73.6
ICD-10 Finland
Limitation of activities due to disability
7.1
6.2
14
20
J01CA08
ATC
pivmecillinam; oral
1.3
6.1
525
4346
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.1
288
2151
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
12.6
6.1
10
8
N04BC05
ATC
pramipexole; oral
2.1
6.1
67
332
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
6.0
204
1425
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.0
223
1588
N04BD01
ATC
selegiline; oral
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
311
124
31.61
307.65
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
327
266
15.56
307.65
1.2
1.5
e6/l
9.2
12.1
0.36
250
213
(3014148) Varicella zoster virus Ab [Titer] in Serum
309
181
21.39
307.65
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
253
80
38.05
307.65
1.1
1.1
u/l
1.0
1.0
0.33
109
39
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
390
292
17.87
307.65
1.2
1.4
mg/l
416.5
499.1
1.88
379
276
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
317
268
14.84
307.65
1.2
1.3
mmol/l
3.5
3.7
2.15
296
251
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
342
93
47.74
307.65
1.1
1.1
mg/l
212.4
224.4
0.35
300
78
(4027681)
287
82
43.33
307.65
1.3
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
191
10
219.64
307.65
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
313
134
29.47
307.65
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
356
92
50.87
307.65
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
327
266
15.56
307.65
1.2
1.6
e6/l
653.0
1927.4
0.56
263
219
(3005719) IgG [Mass/volume] in Serum or Plasma
573
875
10.14
307.65
3.3
2.6
g/l
10.1
10.6
2.12
523
804
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
317
189
21.15
307.65
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
347
241
18.58
307.65
1.2
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
351
99
46.38
307.65
1.2
1.2
mg/l
50.7
32.9
4.85
280
81
(3011412) CD3 cells [#/volume] in Blood
194
89
24.99
267.67
3.8
2.2
e9/l
1.2
1.3
0.31
88
57
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
139
20
76.72
258.46
1.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
133
19
76.93
247.44
1.0
1.1
mg/g
5.0
5.7
0.50
124
19
(3016018) Differential panel - Cerebral spinal fluid
196
112
20.06
245.65
1.2
1.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
156
62
28.06
226.55
4.2
2.2
e9/l
0.3
0.2
1.89
132
55
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
157
64
27.37
225.92
4.2
2.2
e6/l
447.8
578.4
1.06
132
55
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
159
69
25.74
223.50
2.8
1.9
%
15.3
12.2
1.07
75
35
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
288
376
9.30
214.56
2.0
1.6
iu/ml
122.7
0.2
0.58
20
65
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
415
890
6.12
193.43
2.6
2.3
au/ml
33.5
21.7
—
10
77
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
397
823
6.25
191.69
1.4
1.3
au/ml
13.5
29.1
—
6
44
(42870588) Differential panel, method unspecified - Blood
904
3715
4.77
188.41
10.1
5.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
151
87
19.25
187.65
2.5
2.1
%
50.0
36.1
—
51
7
(3023410) Appearance of Cerebral spinal fluid
170
124
15.39
187.14
1.3
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
352
686
6.45
180.51
3.2
1.7
g/l
1.2
1.4
0.88
346
637
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
117
55
23.04
158.62
1.2
1.1
miu/ml
1482.7
1465.2
0.04
117
55
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
126
75
18.29
153.73
4.7
2.2
e6/l
1020.2
684.2
2.82
83
24
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
120
71
18.33
146.75
2.9
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1097
5936
4.43
140.55
11.8
5.7
e9/l
0.6
0.5
1.88
1005
5232
(3022096) Basophils/100 leukocytes in Blood
1031
5349
4.17
140.30
11.4
5.8
%
0.8
0.7
6.87
1008
5017
(3000060) B lymphocytes [#/volume] in Blood
86
23
39.67
140.18
3.2
1.6
e6/l
43.0
226.2
1.97
37
13
(3006315) Basophils [#/volume] in Blood
1096
5957
4.38
138.75
11.8
5.7
e9/l
0.0
0.0
0.01
1005
5239
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
123
88
15.17
136.19
1.2
1.5
mmol/l
1.7
1.9
1.91
117
83
(3006504) Eosinophils/100 leukocytes in Blood
1047
5561
4.13
135.87
11.4
5.7
%
3.0
2.8
1.85
1023
5206
(3019069) Monocytes/100 leukocytes in Blood
1051
5599
4.14
135.73
11.6
5.9
%
9.0
8.1
19.80
1029
5290
(3013115) Eosinophils [#/volume] in Blood
1106
6176
4.28
131.48
11.9
6.0
e9/l
0.2
0.2
0.03
1020
5537
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
83
25
35.14
130.88
4.8
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1102
6154
4.24
130.60
11.8
5.7
e9/l
1.7
2.0
13.50
1015
5535
(3002030) Lymphocytes/100 leukocytes in Blood
1059
5809
4.01
127.59
11.5
5.7
%
26.9
29.2
11.55
1033
5469
(21494814) CD8 cells/100 lymphocytes in Specimen
86
32
28.50
126.90
2.2
2.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1046
5744
3.91
124.54
11.1
5.5
%
58.5
56.6
6.58
1021
5420
(3013650) Neutrophils [#/volume] in Blood by Automated count
1119
6814
3.76
104.90
12.8
8.8
e9/l
3.8
4.0
3.69
1028
6011
(36304419) Bacteria [Presence] in Urine
632
2750
3.29
104.82
4.1
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
627
2761
3.23
101.17
4.1
2.7
e6/l
0.1
0.3
5.42
524
2027
(3000850) Epithelial cells [#/volume] in Urine
524
2074
3.38
101.06
3.4
2.3
e6/l
4.7
7.1
3.57
487
1812
(3002582) Erythrocytes [#/volume] in Urine
665
3032
3.19
101.04
4.4
2.8
e6/l
15.3
111.9
2.24
564
2276
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
102
5
219.12
99.82
1.1
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
81
57
14.99
90.09
1.1
1.6
%
95.2
68.0
—
14
8
(3026782) Osmolality of Urine
473
1924
3.16
84.93
3.5
2.4
mosm/kgh2o
542.6
541.9
0.02
435
1640
(3018095) Leukocytes [#/volume] in Urine
725
3731
2.88
84.69
5.4
3.2
e6/l
43.1
76.8
1.14
587
2487
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
843
4762
2.83
81.27
2.5
2.2
nmol/l
86.5
74.0
21.84
790
4417
(3021879) Hepatitis B virus core Ab [Presence] in Serum
333
1158
3.43
76.73
1.3
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
767
4273
2.68
73.63
3.8
4.7
g/l
37.3
36.6
3.51
714
4009
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
207
536
4.34
72.96
1.4
2.2
u/l
34.5
40.8
5.60
197
491
(3031040) Bacteria [#/volume] in Urine by Automated count
1111
7530
3.00
70.97
7.5
3.7
e6/l
62.4
565.8
—
7
79
(3021589) Normoblasts [#/volume] in Blood
860
5228
2.57
66.50
12.9
8.3
e9/l
0.0
0.0
0.12
733
4292
(3037467) Urinalysis macro (dipstick) panel - Urine
1146
8076
2.96
64.57
6.9
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
552
2934
2.42
54.29
3.9
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
58
57
10.56
52.22
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
49
37
13.67
52.12
1.2
1.1
ng/l
210.4
552.8
—
14
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
388
1796
2.58
51.01
1.5
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
53
52
10.54
47.74
1.2
2.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
231
850
3.04
46.83
5.5
4.2
%
0.0
0.1
1.15
38
188
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
353
1621
2.55
46.71
3.6
2.4
e6/l
0.9
1.3
0.63
207
878
(3021440) Promyelocytes/100 leukocytes in Blood
236
894
2.96
45.35
5.6
4.2
%
0.0
0.2
3.38
43
219
(3017181) Myelocytes/100 leukocytes in Blood
243
944
2.89
44.55
5.5
4.1
%
0.8
1.0
0.22
45
243
(3018677) aPTT in Platelet poor plasma by Coagulation assay
322
1446
2.57
44.42
1.7
2.1
s
29.1
29.4
0.50
305
1397
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
40
28
14.66
44.33
1.8
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
32
15
21.79
42.81
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
225
864
2.90
42.01
5.4
4.0
%
0.3
0.7
2.07
35
179
(3030905) Polymorphonuclear cells [#/volume] in Blood
99
226
4.63
40.46
3.8
4.1
e9/l
3.8
4.2
0.85
99
226
(3009261) Glucose [Presence] in Urine by Test strip
853
5888
2.08
39.85
5.5
3.1
estimate
0.0
0.0
1.06
244
1072
(3035350) Ketones [Presence] in Urine by Test strip
844
5820
2.07
39.33
5.4
3.1
estimate
0.0
0.0
0.50
240
1099
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
99
232
4.51
39.15
3.9
4.4
%
59.6
57.0
1.34
99
232
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
321
1525
2.42
38.72
3.9
2.5
e6/l
5.4
3.1
1.85
178
788
(3021601) Nitrite [Presence] in Urine by Test strip
844
5842
2.06
38.65
6.9
4.2
estimate
0.0
0.0
0.35
247
1131
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
51
63
8.35
38.61
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
178
638
3.04
37.43
1.7
2.7
g/l
68.7
67.9
0.80
167
597
(3037522) Nuclear Ab [Titer] in Serum
361
1862
2.25
35.63
1.4
1.4
titre
430.2
549.8
1.01
86
364
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
497
2923
2.06
34.83
2.5
2.1
u/l
147.9
190.4
0.81
476
2777
(3013826) Glucose [Moles/volume] in Serum or Plasma
867
6206
1.98
34.39
4.9
4.5
mmol/l
6.2
6.5
6.88
819
5687
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
478
2791
2.06
34.02
1.7
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
460
2656
2.07
33.69
2.3
1.4
g/l
2.1
2.3
1.37
354
1711
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
108
308
3.71
32.67
1.3
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
50
76
6.78
31.60
4.4
2.4
%
47.2
45.5
0.15
17
25
(3032080) INR in Blood by Coagulation assay
569
3632
1.93
30.67
5.8
6.4
inr
1.1
1.1
0.12
196
1172
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
785
5601
1.87
29.60
5.0
5.9
umol/l
9.4
10.5
4.53
762
5303
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
163
633
2.77
29.38
2.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
58
110
5.45
29.34
1.2
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
223
1031
2.37
27.91
6.8
3.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
30
28
10.92
27.83
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
30
29
10.54
27.18
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
481
3014
1.89
26.60
9.0
4.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1072
8627
1.92
25.81
6.5
7.0
u/l
72.7
74.7
1.16
1014
8144
(40758558) Short blood count panel - Blood
462
2890
1.88
25.48
7.9
6.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
128
476
2.85
24.94
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
627
4340
1.78
24.58
6.0
5.7
mmol/l
1.2
1.2
0.20
559
3989
(3011397) Hemoglobin [Presence] in Urine by Test strip
420
2576
1.89
24.47
4.8
3.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
29
32
9.23
23.90
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
131
517
2.69
22.76
1.8
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1367
12244
2.87
22.37
14.7
11.1
mg/l
17.8
20.3
2.10
1097
9422
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
102
357
3.00
22.15
1.8
1.7
titre
112.0
201.5
—
5
13
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
674
4874
1.71
21.81
6.5
6.2
mmol/l
1.2
1.2
0.54
534
4135
(46235355) HIV 1 and 2 tests - Meaningful Use set
511
3429
1.75
21.60
1.9
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
191
919
2.24
21.50
2.5
2.2
u/l
739.4
5340.7
5.45
53
381
(3033658) Prothrombin time (PT) actual/Normal
429
2747
1.80
21.24
3.7
3.6
%
97.2
96.2
0.36
417
2659
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
31
44
7.18
20.82
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
26
31
8.52
20.17
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
460
3058
1.74
19.74
6.9
3.3
estimate
0.0
0.0
1.28
249
1112
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
44
6.94
19.57
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1049
8691
1.74
19.33
3.8
3.8
mm/h
10.3
9.9
0.45
975
8167
(3019550) Sodium [Moles/volume] in Serum or Plasma
1337
12014
2.36
18.76
14.5
11.6
mmol/l
139.6
139.6
0.05
1312
11711
(3023103) Potassium [Moles/volume] in Serum or Plasma
1339
12054
2.36
18.46
14.5
11.7
mmol/l
3.9
3.9
1.99
1310
11728
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
29
45
6.55
17.96
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
429
2893
1.68
17.00
3.3
3.8
ph
7.4
7.4
0.39
98
565
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
32
7.61
16.99
1.1
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
60
183
3.38
16.39
1.2
1.9
—
1462.9
—
0
7
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
13
12.43
16.04
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1402
13010
3.02
16.02
14.9
9.0
u/l
26.5
26.3
0.20
1373
12667
(3013512) EKG study
396
2664
1.67
15.62
3.2
3.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
529
3893
1.56
14.12
1.8
1.8
pmol/l
95.7
97.5
0.42
289
2099
(3041096) Erythrocytes [Presence] in Urine by Automated
469
3387
1.57
13.47
5.2
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1260
11360
1.80
13.29
12.6
9.5
ml/min/173m2
94.2
89.9
12.62
1090
9317
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
599
4587
1.52
13.06
6.1
3.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
39
104
3.83
13.03
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1035
8902
1.56
12.93
4.3
2.9
u/l
40.2
40.8
0.10
989
8509
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
130
3.46
12.67
1.5
1.4
g/l
0.3
0.4
1.10
31
90
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
130
3.46
12.67
1.5
1.4
g/l
6.4
6.8
0.24
31
91
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
130
3.46
12.67
1.5
1.4
g/l
3.0
3.0
0.02
31
90
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
11
11.92
12.64
1.1
1.5
—
—
—
0
0
(4062490)
44
133
3.38
12.24
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
541
4124
1.50
11.72
3.7
3.3
u/l
28.1
29.8
1.11
526
3937
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
35
95
3.75
11.43
1.4
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
14
9.36
10.77
1.2
3.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
54
200
2.77
10.65
1.6
1.7
g/l
0.7
0.8
0.27
39
151
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
91
430
2.19
10.63
2.4
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
479
3638
1.47
10.25
3.1
2.9
ng/l
36.6
33.2
0.08
271
1942
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
10
11.08
10.17
1.1
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
337
2397
1.53
9.88
4.5
4.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
15
9
16.83
9.88
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
97
485
2.07
9.82
1.6
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
13
16
8.19
9.74
1.2
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
74
338
2.25
9.41
1.3
1.3
titre
55.0
94.9
—
10
37
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
226
1482
1.62
9.40
1.9
1.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
13
17
7.71
9.28
1.2
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
150
889
1.77
9.09
2.9
2.5
e9/l
4.1
4.2
0.38
127
749
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
91
461
2.04
8.91
1.6
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
276
2.34
8.84
1.6
1.9
g/l
2.9
3.0
0.39
48
222
(3019309) Folate [Moles/volume] in Red Blood Cells
227
1514
1.59
8.77
1.6
1.6
nmol/l
1142.1
1188.6
0.21
171
1202
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
290
2.30
8.75
1.6
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
290
2.30
8.75
1.6
1.9
g/l
7.0
7.3
0.75
51
232
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
22
6.42
8.53
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1234
11363
1.56
8.46
5.3
4.7
mu/l
1.7
2.0
1.09
1156
10726
(3012095) Magnesium [Moles/volume] in Serum or Plasma
235
1596
1.56
8.38
3.1
3.4
mmol/l
0.8
0.8
0.01
219
1509
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
161
996
1.69
8.37
3.5
2.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
290
2.26
8.32
1.6
1.9
g/l
3.6
3.8
0.79
48
216
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
132
785
1.75
7.91
2.9
3.3
mmol/l
1.2
1.2
1.11
113
683
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
24
66
3.68
7.75
1.6
3.6
u/ml
735.0
816.7
0.09
24
66
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
8
15.11
7.72
1.3
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1373
13047
1.90
7.71
14.2
10.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
12
18
6.71
7.61
1.1
1.0
%
87.0
56.4
—
6
5
(3052851) Hemolysis interference index of Serum or Plasma
63
295
2.19
7.59
2.0
2.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
226
2.35
7.47
1.5
1.9
g/l
39.2
38.8
0.17
45
206
(3002385) Erythrocyte distribution width [Ratio]
1163
10652
1.45
7.45
20.7
13.4
%
13.4
13.5
4.50
1149
10445
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
252
2.27
7.43
1.7
2.1
g/l
0.9
0.8
0.11
49
231
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
440
3452
1.39
7.40
2.4
2.5
u/l
52.5
55.0
1.08
408
3233
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
186
1234
1.58
7.31
3.8
3.6
%
30.9
31.5
0.40
143
912
(3003338) MCHC [Mass/volume]
1019
11124
0.72
7.19
21.8
13.8
g/l
332.7
332.9
0.40
1014
11047
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
270
2.16
6.71
1.6
1.9
g/l
11.4
10.7
0.41
50
234
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
70
359
2.00
6.68
1.8
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
285
2110
1.44
6.57
1.5
1.4
nmol/l
19.6
20.9
0.82
255
1875
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
25
5.24
6.49
1.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
186
1272
1.53
6.38
2.1
2.8
umol/l
6.1
7.1
0.55
161
1093
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
175
1188
1.54
6.20
5.4
5.9
mmol/l
1.0
1.0
1.36
162
1121
(3015377) Calcium [Moles/volume] in Serum or Plasma
426
3430
1.34
5.84
2.4
3.2
mmol/l
2.3
2.3
0.48
369
3114
(3029634) Reagin Ab [Titer] in Serum by VDRL
47
219
2.18
5.80
1.3
2.0
—
3.4
—
0
5
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
24
5.03
5.75
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
182
2.29
5.68
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1130
12024
0.73
5.52
3.7
3.7
mmol/l
1.5
1.5
0.06
1041
11404
(3006462) Nitrate [Presence] in Urine
17
47
3.65
5.49
4.1
2.5
—
—
—
0
0
(3019225) pH of Specimen
139
927
1.55
5.35
4.1
3.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
396
1.83
5.34
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
8
11.31
5.29
1.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
796
1.58
5.16
6.0
3.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
115
747
1.59
4.97
6.2
8.1
mmol/l
7.0
8.0
1.25
110
716
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
32
4.09
4.90
1.2
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
32
4.09
4.90
1.2
1.0
%
78.9
103.3
1.64
13
32
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
7
11.48
4.78
1.1
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
46
232
2.01
4.68
1.2
1.3
u/ml
3.9
6.1
0.51
17
94
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
143
989
1.49
4.66
1.8
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
64
1083
0.57
4.65
1.6
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1156
12197
0.75
4.62
4.0
4.0
mmol/l
2.9
2.9
0.13
1060
11538
(3007461) Platelets [#/volume] in Blood
1425
13897
2.12
4.58
25.9
16.4
e9/l
265.5
261.0
1.92
1410
13634
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
69
401
1.76
4.57
1.9
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
98
2.58
4.56
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1058
9789
1.29
4.56
4.3
4.1
pmol/l
14.7
14.4
4.40
967
9188
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
53
284
1.90
4.55
1.6
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
1426
13913
2.14
4.53
25.7
16.3
fl
90.7
90.3
3.19
1416
13777
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
8
10.05
4.52
1.1
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
1426
13915
2.13
4.49
25.7
16.3
pg
30.2
30.1
1.24
1416
13777
(3026361) Erythrocytes [#/volume] in Blood
1426
13916
2.13
4.48
25.8
16.3
e12/l
4.5
4.5
0.56
1411
13636
(3010813) Leukocytes [#/volume] in Blood
1426
13918
2.12
4.44
25.9
16.4
e9/l
6.6
6.7
1.07
1408
13630
(3016650) Hepatitis A virus Ab [Presence] in Serum
47
244
1.96
4.43
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
189
2.09
4.43
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1143
12065
0.76
4.43
3.7
3.8
mmol/l
4.8
4.8
0.75
1060
11481
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
100
648
1.58
4.39
1.1
1.3
miu/ml
220.1
217.1
0.03
41
333
(3045414) Leukocytes [Presence] in Urine
84
522
1.65
4.37
1.6
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1426
13922
2.11
4.37
26.0
16.4
g/l
136.0
136.2
0.29
1416
13783
(4211845)
17
55
3.12
4.37
4.1
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
41
204
2.04
4.35
1.4
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
23
89
2.61
4.31
1.1
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
6
11.71
4.28
1.1
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
162
1170
1.43
4.24
2.2
2.1
nmol/l
358.0
373.6
0.53
148
1096
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
108
2.43
4.23
1.4
2.0
mg/l
23.6
23.5
—
9
33
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
51
3.16
4.21
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
36
3.63
4.21
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
182
1347
1.40
4.15
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
134
1871
0.69
4.14
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
62
361
1.75
4.11
1.3
1.3
u/ml
4.0
9.9
—
10
64
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1093
11579
0.78
4.10
3.4
3.4
mmol/l
1.3
1.3
0.41
1008
10964
(3023183) Ammonium ion [Moles/volume] in Plasma
41
210
1.98
4.04
2.0
3.4
umol/l
34.5
33.3
0.10
34
191
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
58
2.95
4.01
1.4
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
178
2.05
3.91
1.9
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
125
2.26
3.91
1.3
1.5
mmol/l
47.9
72.0
2.88
20
110
(3007853) Bacteria identified in Skin by Aerobe culture
177
1320
1.39
3.87
2.6
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
11
7.31
3.86
1.1
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
140
1004
1.44
3.82
1.8
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
15
6.03
3.82
2.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
108
2.34
3.77
1.2
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
49
274
1.82
3.74
1.3
1.2
—
10.8
—
0
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
96
2.42
3.73
3.8
3.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
60
357
1.71
3.71
1.3
1.3
u/ml
2.1
2.4
—
7
39
(3004616) Nuclear Ab [Presence] in Serum
31
149
2.10
3.64
1.3
1.2
—
—
—
0
0
(4268621)
32
157
2.06
3.57
2.0
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
259
2071
1.30
3.56
1.6
1.6
pmol/l
459.5
26969793.3
2.06
223
1828
(3012501) Base excess in Blood by calculation
39
207
1.91
3.51
2.6
2.8
mmol/l
2.5
2.3
0.26
30
128
(3006653) Thiamine [Moles/volume] in Blood
17
63
2.72
3.49
1.4
1.7
nmol/l
140.6
142.5
0.06
17
63
(3023420) DNA double strand Ab [Units/volume] in Serum
30
146
2.08
3.43
1.2
1.8
—
20.1
—
0
8
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
226
1784
1.32
3.41
3.1
3.3
ng/l
242.6
483.3
0.72
122
1095
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
132
957
1.42
3.41
3.0
4.5
u/l
218.4
233.5
1.17
127
914
(1761868) Lipid panel - Serum or Plasma
442
5099
0.81
3.39
2.3
2.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
10
7.03
3.36
1.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
67
423
1.61
3.34
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
255
1.79
3.32
2.3
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
126
911
1.42
3.31
2.3
2.3
g/l
0.2
0.2
0.01
120
858
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
65
2.63
3.31
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
48
278
1.75
3.30
1.3
1.3
u/ml
1.0
5.0
—
6
22
(3022313) Gas panel - Capillary blood
64
401
1.62
3.29
3.6
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
113
1560
0.70
3.28
1.7
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
26
123
2.13
3.21
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
28
3.59
3.20
3.8
2.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
54
327
1.68
3.18
1.3
1.9
g/l
1.5
1.4
0.14
47
284
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
67
2.56
3.13
2.1
2.0
u/field
2.6
2.8
—
9
34
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
20
4.52
3.11
2.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
8
7.53
3.05
2.0
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
140
2.02
3.01
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
53
325
1.65
2.99
2.1
2.1
ug/l
2.9
2.5
0.06
41
298
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
51
2.76
2.99
1.5
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
51
2.76
2.99
1.2
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
5
10.03
2.98
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
90
624
1.47
2.98
2.1
2.7
e9/l
67.1
74.8
1.27
63
457
(3014576) Chloride [Moles/volume] in Serum or Plasma
141
1060
1.37
2.97
9.6
7.1
mmol/l
103.6
104.5
0.86
136
1043
(3000093) Morphology [Interpretation] in Blood Narrative
17
69
2.48
2.96
1.5
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
236
1.76
2.91
1.1
1.2
u/ml
1.6
5.0
—
10
68
(3036489) Thrombin time
70
463
1.54
2.90
1.5
2.1
s
21.0
21.0
0.01
59
395
(36660697) Celiac disease serology panel - Serum
141
1065
1.36
2.88
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
122
2.07
2.88
1.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
76
1100
0.67
2.87
1.5
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
13
5.40
2.87
1.6
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
186
1472
1.30
2.77
2.2
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
65
428
1.54
2.76
1.2
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
127
951
1.37
2.75
11.1
9.3
kpa
12.7
13.0
0.27
117
914
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
127
951
1.37
2.75
11.2
9.3
kpa
5.0
5.1
0.34
116
911
(3019174) dRVVT (LA screen)
7
14
5.02
2.73
1.6
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
98
2.16
2.71
2.3
2.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
37
2.99
2.69
3.1
2.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
168
1.86
2.68
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
235
1.72
2.67
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
15
4.68
2.60
2.0
2.5
u/field
0.4
0.7
—
7
15
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
67
452
1.51
2.57
14.2
13.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
11
5.47
2.54
2.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
292
2466
1.23
2.52
6.3
3.3
kg/l
1.0
1.0
0.08
38
336
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
172
1.82
2.51
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
172
1.82
2.51
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
151
1911
0.77
2.50
1.4
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
284
0.42
2.48
1.1
1.0
u/ml
3.6
2.7
—
7
101
(3049717) Cytology report of Urine Cyto stain
41
249
1.67
2.45
1.9
2.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
51
2.56
2.44
1.5
1.5
—
—
—
0
0
(4024509)
18
83
2.18
2.41
2.2
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
90
2.13
2.39
1.1
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
124
949
1.34
2.36
11.3
9.3
mmol/l
1.1
0.9
0.23
91
739
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
95
697
1.39
2.36
1.6
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
324
2792
1.21
2.28
1.6
1.8
mg/l
0.9
0.9
0.04
216
2081
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
141
1.86
2.28
1.3
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
77
549
1.42
2.26
3.7
3.1
ph
7.4
7.4
0.64
11
68
(3037756) Immunofixation for Serum or Plasma
26
142
1.85
2.24
1.8
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
24
3.35
2.18
1.1
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
24
130
1.86
2.13
1.4
1.4
pmol/l
295.0
370.9
0.27
16
101
(40767503) Oxygen content in Capillary blood by calculation
30
175
1.73
2.10
2.5
2.0
%
15.5
16.6
—
10
81
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
74
532
1.41
2.10
3.6
3.1
mmol/l
1.5
1.6
0.03
63
388
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
25
3.21
2.09
2.8
4.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
25
3.21
2.09
8.0
9.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
546
4953
1.16
2.08
2.0
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
355
3110
1.19
2.08
1.3
1.3
u/ml
1.4
1.5
0.05
83
879
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
260
0.46
2.03
1.1
1.1
u/ml
4.2
4.7
—
5
96
(3044889) 12 lead EKG panel
823
7707
1.16
2.02
3.3
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
308
2679
1.19
1.95
2.2
2.0
mg/l
2.8
2.8
0.03
270
2326
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
371
0.56
1.92
1.1
1.1
u/ml
0.2
1.7
—
6
140
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
85
2.01
1.90
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
85
2.01
1.90
1.1
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
107
830
1.31
1.90
12.1
10.1
%
96.4
96.3
0.02
101
807
(3027945) Reticulocytes/100 erythrocytes in Blood
115
901
1.30
1.90
2.9
2.5
%
1.6
1.8
1.72
100
812
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
274
2364
1.20
1.90
1.2
1.3
iu/ml
18.5
27.6
0.85
67
728
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
141
1136
1.27
1.88
7.3
5.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
175
1449
1.24
1.84
2.2
2.2
g/l
2.4
2.4
0.16
162
1350
(3039162) Centromere protein B Ab [Units/volume] in Serum
29
175
1.67
1.83
1.2
1.3
—
41.3
—
0
12
(3005322) IgE [Units/volume] in Serum or Plasma
123
979
1.28
1.81
1.2
1.3
u/ml
80.0
224.1
4.21
110
913
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
73
2.07
1.81
1.3
1.5
u/l
5.6
5.1
—
5
31
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
87
1.97
1.80
1.1
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
190
1599
1.22
1.72
2.3
2.2
umol/l
13.6
14.3
0.57
176
1487
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
335
2971
1.17
1.67
1.6
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
19
3.17
1.66
1.7
2.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
14
3.58
1.61
1.2
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
47
659
0.70
1.59
1.7
1.8
mg/l
3.9
4.2
0.07
34
454
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
159
1326
1.22
1.59
2.3
2.3
%
23.6
24.2
0.19
136
1153
(3013727) Leukocytes other/100 leukocytes in Blood
6
20
3.01
1.58
4.8
3.9
%
56.1
50.1
—
6
20
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
56
407
1.39
1.56
1.6
2.3
%
97.9
93.8
0.77
51
367
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
107
1.79
1.55
1.5
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
107
1.79
1.55
1.1
1.2
u/l
39.7
55.0
—
10
73
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
527
0.68
1.55
1.6
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
99
787
1.28
1.51
13.2
10.2
g/l
122.6
123.1
0.11
92
764
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
108
1.77
1.51
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
108
1.77
1.51
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
108
1.77
1.51
1.2
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
21
2.86
1.50
2.8
1.3
mmol/l
2.4
2.6
—
6
21
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
154
1.63
1.50
1.7
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
319
0.59
1.50
1.1
1.1
u/ml
0.0
1.4
—
6
134
(3023419) Bacteria identified in Sputum by Culture
20
116
1.73
1.49
2.8
2.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
45
2.23
1.46
1.2
2.3
—
73985.5
—
0
6
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
341
0.61
1.46
1.0
1.1
u/ml
0.8
6.6
—
10
180
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
30
449
0.66
1.45
1.4
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
102
1.77
1.45
1.2
1.1
ratio
1.0
1.0
—
6
47
(3048689) Calprotectin [Mass/mass] in Stool
203
1750
1.19
1.44
2.2
2.5
ug/g
91.5
106.7
0.37
143
1401
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
95
1180
0.79
1.42
2.9
2.5
ug/l
0.7
0.7
0.17
66
671
(3050129) First trimester maternal screen panel - Serum or Plasma
61
802
0.75
1.41
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
19
111
1.72
1.39
1.6
1.7
mosm/kgh2o
271.2
283.3
0.49
14
88
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
29
2.42
1.39
4.1
2.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
29
2.42
1.39
2.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
75
1.88
1.34
1.6
1.6
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
40
0.00
1.32
0.0
2.1
—
78.8
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
36
250
1.45
1.31
1.9
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
90
722
1.26
1.31
3.8
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
588
0.72
1.30
2.6
2.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
45
327
1.39
1.29
8.4
8.4
%
1.8
1.7
0.60
40
306
(3007930) Methemoglobin/Hemoglobin.total in Blood
45
327
1.39
1.29
8.4
8.4
%
0.9
0.9
0.16
40
306
(4306422)
34
235
1.46
1.28
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
55
2.01
1.27
1.1
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
231
2037
1.16
1.26
2.3
3.0
ng/l
628.0
806.4
0.61
190
1677
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.2
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
30
203
1.49
1.25
4.0
3.7
mg/l
24.7
30.0
0.62
25
164
(3034860) Kappa light chains.free [Mass/volume] in Serum
30
203
1.49
1.25
4.0
3.7
mg/l
34.0
38.8
0.31
25
165
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
295
1.40
1.25
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
44
321
1.38
1.24
1.1
1.4
u/l
25.7
23.1
0.25
35
266
(3047352) Trisomy 18 risk [Likelihood] in Fetus
40
547
0.72
1.22
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
108
1.68
1.22
1.2
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
28
188
1.50
1.22
3.5
2.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
16
93
1.73
1.21
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
67
524
1.29
1.20
6.2
6.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
40
544
0.73
1.19
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
239
1.43
1.19
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
102
1228
0.82
1.18
1.4
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
23
149
1.55
1.17
1.5
1.3
nmol/l
—
0.5
—
0
6
(3020717) Zinc [Moles/volume] in Serum or Plasma
15
87
1.73
1.15
1.6
1.4
umol/l
16.4
28.7
1.39
15
82
(3051611) Lipemic interference index of Serum or Plasma
16
95
1.69
1.14
1.3
3.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
25
366
0.68
1.13
1.2
1.7
nmol/l
36.3
39.1
0.38
25
356
(3035880) pH of Pleural fluid
7
30
2.34
1.12
1.1
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
95
783
1.23
1.12
12.1
7.5
mmol/l
1.2
1.3
0.24
88
758
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
568
1.26
1.09
2.2
2.9
ng/l
79.6
145.3
2.37
63
502
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
21
2.39
1.09
1.0
3.7
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
279
1.37
1.06
1.2
1.3
u/ml
345.0
258.1
0.53
24
181
(3051651) Icteric interference index of Serum or Plasma
12
67
1.80
1.04
1.1
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
246
2728
0.88
1.04
5.1
4.0
mg/mmol
14.5
9.3
0.37
157
1754
(3002032) Base excess in Venous blood by calculation
91
754
1.22
1.03
4.4
3.5
mmol/l
1.6
1.8
0.31
79
605
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
36
264
1.37
1.02
1.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
264
1.37
1.02
1.5
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
47
1.92
1.02
1.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
230
1.40
1.02
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
177
0.56
1.02
1.9
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
43
561
0.76
1.00
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
49
1.84
0.98
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
159
0.56
0.98
1.2
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
59
472
1.26
0.93
2.4
2.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
350
0.71
0.93
1.3
1.4
nmol/l
0.4
0.5
0.10
18
283
(3001122) Ferritin [Mass/volume] in Serum or Plasma
633
6018
1.09
0.92
2.8
2.8
ug/l
97.3
90.0
0.37
603
5690
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
110
1.55
0.90
1.1
1.5
umol/l
11.2
10.4
0.22
17
102
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
81
675
1.21
0.90
4.1
3.8
ng/l
84.1
79.2
0.17
70
607
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
254
0.67
0.89
1.4
1.8
pmol/l
221.6
205.5
0.23
17
243
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
135
1.49
0.89
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
160
1.44
0.89
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
122
1058
1.17
0.87
2.7
2.4
u/l
28.8
39.8
1.60
106
902
(3021387) Prolactin [Units/volume] in Serum or Plasma
65
789
0.82
0.86
1.6
1.6
mu/l
316.4
303.9
0.08
56
706
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
579
1.22
0.84
1.7
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
140
1587
0.87
0.84
3.5
3.6
%
20.2
21.1
0.31
65
634
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
45
1.78
0.84
1.1
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
248
1.34
0.84
1.3
1.4
u/ml
81.3
104.0
—
6
46
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
46
1.74
0.82
4.0
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
111
961
1.17
0.82
11.7
15.5
inr
1.1
1.2
0.56
23
158
(3009508) Creatinine [Moles/volume] in Urine
283
3069
0.90
0.82
4.3
3.3
mmol/l
7.4
8.0
1.25
231
2653
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
35
267
1.32
0.81
1.3
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
38
295
1.30
0.79
8.8
9.2
mmol/l
1.2
1.2
0.13
32
254
(3008152) Bicarbonate [Moles/volume] in Arterial blood
61
502
1.22
0.78
9.1
9.0
mmol/l
24.3
24.4
0.07
53
470
(3011648) Oxygen content in Venous blood
12
74
1.63
0.78
1.9
2.1
%
12.0
11.6
0.11
12
74
(3003694) ABO and Rh group [Type] in Blood
359
3838
0.91
0.77
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
821
0.83
0.77
1.4
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
28
0.00
0.76
0.0
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
28
0.00
0.76
0.0
3.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
48
387
1.25
0.75
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
75
1.60
0.75
1.8
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
24
2.09
0.74
1.4
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
47
379
1.25
0.73
4.2
2.4
%
0.7
0.7
0.00
47
370
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
242
0.70
0.73
2.1
2.5
ug/min
46.6
116.0
1.04
11
149
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
176
1.37
0.73
1.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
231
2119
1.11
0.72
1.5
1.7
—
—
—
0
0
(4010399)
89
767
1.17
0.72
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
134
1.42
0.71
1.4
1.3
nmol/l
—
—
—
0
0
(44813793)
15
101
1.49
0.70
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
82
706
1.17
0.68
14.6
9.2
—
—
—
0
0
(3000492) Spirometry study
117
1317
0.88
0.67
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
275
2953
0.92
0.66
1.5
1.6
mmol/l
1.5
1.4
0.57
223
2567
(4034850)
31
394
0.78
0.65
7.1
7.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
120
1.42
0.64
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
242
2609
0.91
0.64
4.2
3.3
mg/l
666.2
374.3
0.30
152
1685
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
49
588
0.83
0.63
1.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
113
1.42
0.61
1.9
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
20
0.00
0.60
0.0
1.8
—
1.2
—
0
20
(3032868) Hemoglobin electrophoresis panel in Blood
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
21
0.00
0.60
0.0
1.0
—
0.2
—
0
14
(3024928) Oxygen saturation in Venous blood
24
183
1.32
0.59
2.9
3.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
61
713
0.85
0.59
1.4
1.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
22
0.00
0.59
0.0
2.2
—
1.2
—
0
22
(4198724)
11
72
1.53
0.59
1.4
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
182
1670
1.10
0.59
2.2
2.6
mmol/l
2.4
2.4
0.11
159
1468
(3000330) Specific gravity of Urine by Test strip
55
465
1.19
0.58
3.1
2.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
208
0.72
0.58
2.9
3.4
mg/l
43.7
23.2
—
6
134
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
89
1.46
0.58
2.8
2.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
43
516
0.83
0.56
1.1
1.3
u/l
12.9
10.7
0.39
35
426
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
73
1.51
0.56
6.0
6.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
90
1.45
0.55
1.2
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
169
1555
1.10
0.53
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
83
1.45
0.52
3.1
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
40
1.50
0.51
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
42
352
1.20
0.50
3.0
3.6
g/l
0.4
0.2
0.65
16
149
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
22
280
0.78
0.50
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
41
1.47
0.50
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1206
11900
1.08
0.50
17.7
11.7
%
39.9
40.3
1.21
901
9655
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
125
1137
1.11
0.50
1.2
1.2
iu/ml
165.6
143.9
0.25
48
447
(3003327) Ova and parasites identified in Stool by Light microscopy
42
497
0.84
0.49
1.9
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
57
657
0.86
0.49
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
56
646
0.86
0.49
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
57
656
0.86
0.48
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
58
503
1.16
0.48
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
87
777
1.13
0.48
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
198
1847
1.08
0.47
2.0
1.8
%
1.5
1.4
0.66
181
1674
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
146
1.31
0.47
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
85
1.42
0.47
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
182
1.27
0.46
1.1
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
41
347
1.19
0.46
4.6
2.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
78
1.41
0.43
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
58
659
0.88
0.43
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
58
658
0.88
0.42
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
143
1543
0.92
0.42
1.8
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
149
1.28
0.42
1.4
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
149
1.28
0.42
1.8
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
184
0.76
0.42
1.4
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
8
58
1.38
0.41
1.8
2.9
ml
1736.2
1989.2
—
8
53
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.3
—
0
7
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
136
1258
1.09
0.41
1.4
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
79
1.40
0.40
2.2
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
79
1.40
0.40
3.0
2.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(4133840)
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
35
1.43
0.39
2.6
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
36
307
1.18
0.38
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
73
810
0.90
0.38
3.3
4.4
ug/l
6.1
18.6
0.88
54
624
(40768441) Liver Pathology biopsy report
12
89
1.35
0.38
1.0
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
42
364
1.16
0.37
1.8
2.0
iu/l
8.2
4.6
0.57
13
137
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
61
682
0.89
0.37
1.5
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
42
1.43
0.35
2.5
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
245
1.19
0.35
2.1
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
154
1.24
0.34
4.8
4.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
210
1.19
0.32
3.1
3.9
u/ml
0.3
0.4
0.32
13
102
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
98
905
1.09
0.32
3.1
3.3
pmol/l
4.4
4.6
1.41
84
811
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
267
1.16
0.31
1.7
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
60
542
1.11
0.31
6.0
2.9
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
175
0.80
0.31
1.6
1.6
mmol/l
7.2
7.5
—
8
103
(3025130) Human papilloma virus identified in Specimen
32
278
1.15
0.29
1.7
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
56
1.25
0.29
1.1
1.1
iu/ml
484.2
161.5
—
7
56
(1761482) Bacteria [#/volume] in Urine by Culture
17
206
0.82
0.29
5.8
3.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
35
307
1.14
0.29
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
64
1.25
0.27
1.1
1.1
mmol/l
4.9
6.5
—
8
57
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
131
1.22
0.27
1.3
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
75
1.20
0.25
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
75
1.20
0.25
3.2
3.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
75
1.20
0.25
1.2
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
236
1.15
0.24
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
114
1207
0.94
0.24
1.7
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
237
1.14
0.23
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
38
1.32
0.23
7.2
3.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.2
2.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
93
0.75
0.22
1.7
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
40
1.25
0.22
1.2
2.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
568
5574
1.03
0.22
3.7
3.9
—
—
—
0
0
(3017704) Immunofixation for Urine
5
41
1.22
0.22
5.2
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
42
1.19
0.21
1.8
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
39.3
—
0
10
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
1.2
—
0
7
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
43
1.16
0.21
2.4
1.5
ug/l
10.1
8.0
—
5
43
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
328
3194
1.03
0.20
1.6
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
136
1.18
0.20
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
136
1.18
0.20
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
136
1.18
0.20
1.4
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
49
1.23
0.20
1.3
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
51
1.18
0.19
1.7
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
154
0.84
0.19
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
137
1.17
0.19
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
53
1.13
0.18
1.5
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
109
1.19
0.18
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
58
620
0.93
0.17
4.7
2.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
119
1.18
0.17
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
61
1.15
0.17
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
138
1.16
0.17
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
138
1.16
0.17
1.4
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
110
1.18
0.17
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
131
0.84
0.17
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
70
741
0.94
0.16
1.9
2.1
nmol/l
12.1
12.5
0.15
63
675
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
162
0.86
0.16
1.6
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
277
0.90
0.16
1.2
1.2
—
—
—
0
0
(4094501)
28
254
1.10
0.16
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
318
0.91
0.16
1.9
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
27
297
0.91
0.15
1.9
3.4
mg/l
1.3
1.4
0.46
21
277
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1152
11452
1.03
0.15
3.8
3.7
mmol/l
5.7
5.7
1.86
1056
10743
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
27
245
1.10
0.15
1.1
1.0
u/ml
1.6
2.2
0.40
12
125
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
79
1.14
0.15
4.6
2.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
82
860
0.95
0.15
1.8
2.1
ml/min/173m2
73.7
75.6
0.18
33
325
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
24
217
1.11
0.14
1.0
1.1
iu/ml
1.1
2238.9
—
7
58
(3020491) Glucose [Moles/volume] in Blood
10
84
1.19
0.14
1.2
1.5
mmol/l
5.5
6.0
—
10
60
(3045142) Bone marrow Pathology biopsy report
8
96
0.83
0.13
1.0
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
642
0.95
0.13
1.8
2.2
ug/l
7.3
6.9
0.06
52
579
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
203
1983
1.03
0.12
4.1
3.9
ug/l
1.6
1.9
0.92
174
1812
(3000764) Benzodiazepines [Presence] in Urine
74
772
0.96
0.12
4.1
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
191
1.10
0.11
1.1
1.1
—
—
—
0
0
(44790048)
16
143
1.12
0.11
1.6
1.4
—
—
—
0
0
(44790049)
16
143
1.12
0.11
1.6
1.4
—
—
—
0
0
(44806118)
16
143
1.12
0.11
1.6
1.4
—
—
—
0
0
(44790047)
16
143
1.12
0.11
1.6
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
223
2277
0.98
0.11
2.1
2.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
124
1.13
0.11
1.3
1.6
%
62.3
53.5
—
8
86
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
35
373
0.94
0.11
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
80
771
1.04
0.10
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
217
0.92
0.09
1.2
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
107
1.12
0.08
1.2
2.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
58
1.03
0.08
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
379
0.95
0.08
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
34
322
1.06
0.08
1.4
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
990
9944
0.99
0.08
3.4
3.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
74
0.81
0.07
1.7
2.1
ml
1154.8
612.9
—
6
48
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
55
530
1.04
0.07
1.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
355
3588
0.99
0.07
2.2
2.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
80
0.87
0.07
1.1
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
118
1.10
0.07
1.2
1.8
nmol/l
20.6
19.7
0.22
13
111
(3008898) HLA-B27 [Presence]
62
640
0.97
0.07
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
76
781
0.97
0.06
4.1
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
102
0.88
0.06
1.9
2.0
pg
32.9
32.4
—
9
102
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
231
2281
1.02
0.06
1.3
1.3
u/ml
3.5
10.4
3.55
83
959
(3038515) Glucose [Moles/volume] in Venous blood
17
158
1.08
0.06
2.8
2.8
mmol/l
7.6
7.2
0.44
17
153
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
164
1665
0.98
0.06
1.7
1.9
—
—
—
0
0
(4281824)
11
121
0.91
0.06
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
375
0.96
0.06
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.1
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
90
1.11
0.05
2.5
2.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.1
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
76
778
0.98
0.05
4.0
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
75
766
0.98
0.04
3.7
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
302
0.96
0.04
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
270
2678
1.01
0.04
2.2
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
251
0.96
0.04
1.3
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
18
170
1.06
0.04
2.8
2.7
mmol/l
1.7
1.5
0.27
18
163
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
36
372
0.97
0.04
1.2
1.5
pmol/l
59.2
115.6
1.03
36
366
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
253
2551
0.99
0.04
2.2
2.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
92
1.09
0.03
1.7
1.3
—
62.6
—
0
12
(3020891) Body temperature
33
320
1.03
0.03
6.7
4.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
201
1.05
0.03
2.9
2.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1059
10573
1.01
0.02
4.5
4.6
mmol/mol
37.5
38.5
3.08
976
10024
(3026493) Urate [Moles/volume] in Serum or Plasma
279
2804
0.99
0.02
2.4
2.3
umol/l
3073.2
4122.4
0.26
246
2494
(3013139) Helicobacter pylori Ag [Presence] in Stool
83
820
1.01
0.02
1.2
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
93
1.08
0.02
2.5
2.4
mmol/l
4.2
4.0
—
10
93
(3035285) Chloride [Moles/volume] in Venous blood
10
93
1.08
0.02
2.5
2.4
mmol/l
103.3
105.5
—
10
93
(3016879) Cocaine [Presence] in Urine
73
721
1.01
0.01
4.1
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
253
1.03
0.01
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
313
1.02
0.01
1.5
1.4
ug/g
313.7
306.5
0.06
17
172
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
136
0.96
0.00
1.1
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
174
1.03
0.00
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
194
1.03
0.00
2.5
2.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
104
0.96
0.00
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
114
0.96
0.00
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
268
1.01
0.00
1.2
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
111
0.99
0.00
1.2
1.5
g/l
0.9
1.0
0.23
11
111
(3035637) Corticotropin [Mass/volume] in Plasma
14
139
1.01
0.00
1.5
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
149
1492
1.00
0.00
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
137
1.02
0.00
3.4
2.1
—
—
—
0
0
(4035726)
91
907
1.00
0.00
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
70
695
1.01
0.00
1.3
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
11
105
1.05
0.00
3.2
3.3
u/ml
16.6
64.3
1.72
11
105
(40768800) Prostate Pathology biopsy report
10
105
0.95
0.00
1.0
1.2
—
—
—
0
0
(4146454)
7
77
0.91
0.00
2.3
2.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
2.0
2.5
umol/l
60.2
50.3
—
5
49
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
80
1.00
0.00
1.0
1.4
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
22
220
1.00
0.00
1.6
1.4
mmol/l
5.9
7.2
2.40
17
151
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
9
0.00
0.00
0.0
2.0
—
136.2
—
0
9
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
6.5
—
0
8
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
98
0.92
0.00
1.7
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
55
0.91
0.00
1.4
1.2
%
111.6
109.4
—
5
45
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
8.2
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
93
0.97
0.00
3.6
7.1
mmol/l
6.9
7.2
—
9
74
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
197.4
—
0
5
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
2.7
1.6
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_OTHDEMYEL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_OTHDEMYEL | 2.092 [1.77, 2.47] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.142 |
During the follow-up period (1.1.1998 — 31.12.2019), 246 out of 4099 females with G6_OTHDEMYEL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_OTHDEMYEL | 2.444 [2.08, 2.87] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 304 out of 2166 males with G6_OTHDEMYEL died.
Mortality risk
Mortality risk for people of age
years, who have G6_OTHDEMYEL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.224% | 0.37% |
| 5 | 1.238% | 2.478% |
| 10 | 2.828% | 5.803% |
| 15 | 5.52% | 11.151% |
| 20 | 9.909% | 18.746% |
Relationships between endpoints
↥Index endpoint: G6_OTHDEMYEL – Other demyelinating diseases of the central nervous system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data